AI assistant
Sending…
Ernexa Therapeutics Inc. — Director's Dealing 2017
Dec 7, 2017
35259_dirs_2017-12-07_18743883-f685-4196-93a9-3571c4cc56e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2017-12-07
Reporting Person: Simtob Richard Isaac (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-07 | Common Stock | P | 4100 | $3.95 | Acquired | 45536 | Direct |
| 2017-12-07 | Common Stock | P | 100 | $3.97 | Acquired | 45636 | Direct |
| 2017-12-07 | Common Stock | P | 800 | $4.00 | Acquired | 46436 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 155 | Indirect |
Footnotes
F1: Owned by minor child.
More from Ernexa Therapeutics Inc.
Major Shareholding Notification
2026
May 14
Annual Report
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 24